文献速递心脑血管急症

1999-2014年美国 Medicare 人群中颈动脉内膜剥脱术与颈动脉支架置入术的应用

Carotid Endarterectomy and Carotid Artery Stenting in the US Medicare Population, 1999-2014.
PubMed 文献 · JAMA · 2017-01-01
一句话结论1999-2014年美国老年医保人群中颈动脉内膜剥脱术实施率下降,支架置入术先升后降,尽管血管危险因素增加,两种血运重建术后结局均改善。

该研究为1999至2014年对65岁及以上Medicare按服务收费受益人的系列横断面分析,采用住院与参保人数据库,拟合空间混合模型计算县水平风险标化血运重建率,并校正人口学、合并症与症状状态后评估结局趋势。共937111例患者接受颈动脉内膜剥脱术,231077例接受颈动脉支架置入术。内膜剥脱术数量从1999年81306例降至2014年36325例,全国率从1999-2000年每10万受益年298例降至2013-2014年128例(P < .001);支架置入术从1999年10416例升至2006年22865例,率从1999-2000年40例升至2005-2006年75例(P < .001),2014年降至10208例、率38例(P < .001)。校正后30天缺血性卒中或死亡年降幅在内膜剥脱术为2.90%(95%CI 2.63%至3.18%),支架置入术为1.13%(95%CI 0.71%至1.54%);1999至2014年绝对降幅内膜剥脱术为1.4%(95%CI 1.2%至1.5%),支架置入术为-0.1%(95%CI -0.5%至0.4%)。1年缺血性卒中率在内膜剥脱术后绝对下降3.5%(95%CI 3.2%至3.7%),支架置入术后绝对下降1.6%(95%CI 1.2%至2.1%)。

要点

  • 1999-2014年美国Medicare按服务收费受益人中,颈动脉内膜剥脱术全国率从每10万受益年298例降至128例(P < .001)。
  • 颈动脉支架置入术率从1999-2000年40例升至2005-2006年75例(P < .001),后降至2013-2014年38例(P < .001)。
  • 校正后30天缺血性卒中或死亡年降幅:内膜剥脱术2.90%(95%CI 2.63%至3.18%),支架置入术1.13%(95%CI 0.71%至1.54%)。
  • 1999至2014年30天缺血性卒中或死亡绝对降幅:内膜剥脱术1.4%(95%CI 1.2%至1.5%),支架置入术-0.1%(95%CI -0.5%至0.4%)。
  • 1年缺血性卒中绝对降幅:内膜剥脱术3.5%(95%CI 3.2%至3.7%),支架置入术1.6%(95%CI 1.2%至2.1%)。

适用人群与场景

  • 1999至2014年美国Medicare按服务收费受益人,年龄65岁及以上。

研究设计与关键结果

  • 研究类型为1999至2014年系列横断面分析,使用Medicare住院与参保人数据库,共937111例患者接受颈动脉内膜剥脱术(平均年龄75.8岁,43%女性),231077例接受颈动脉支架置入术(平均年龄75.4岁,49%女性)。
  • 颈动脉内膜剥脱术患者数从1999年81306例降至2014年36325例,全国率从1999-2000年每10万受益年298例降至2013-2014年128例(P < .001)。
  • 颈动脉支架置入术患者数从1999年10416例升至2006年22865例,率从1999-2000年每10万受益年40例升至2005-2006年75例(P < .001);2014年为10208例,率降至38例(P < .001)。
  • 校正后30天缺血性卒中或死亡年降幅:内膜剥脱术2.90%(95%CI 2.63%至3.18%),支架置入术1.13%(95%CI 0.71%至1.54%);1999至2014年绝对降幅内膜剥脱术1.4%(95%CI 1.2%至1.5%),支架置入术-0.1%(95%CI -0.5%至0.4%)。
  • 1年缺血性卒中率绝对降幅:内膜剥脱术3.5%(95%CI 3.2%至3.7%),校正后年降幅2.17%(95%CI 2.00%至2.34%);支架置入术绝对降幅1.6%(95%CI 1.2%至2.1%),校正后年降幅1.86%(95%CI 1.45%至2.26%)。
  • 住院死亡率、30天卒中、心肌梗死或死亡、30天全因死亡率以及各人口学亚组均观察到额外改善。
  • 尽管血管危险因素增加(内膜剥脱术患者高血压患病率从67%升至81%,支架置入术患者从61%升至70%)及症状性患者比例增加(所有P < .001),结局仍改善。

证据类型、等级与局限

  • 证据类型:1999至2014年系列横断面分析。
  • 局限:原文未报告局限性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Carotid endarterectomy and carotid artery stenting are the leading approaches to revascularization for carotid stenosis, yet contemporary data on trends in rates and outcomes are limited.

OBJECTIVE: To describe US national trends in performance and outcomes of carotid endarterectomy and stenting among Medicare beneficiaries from 1999 to 2014.

DESIGN, SETTING, AND PARTICIPANTS: Serial cross-sectional analysis of Medicare fee-for-service beneficiaries aged 65 years or older from 1999 to 2014 using the Medicare Inpatient and Denominator files. Spatial mixed models adjusted for age, sex, and race were fit to calculate county-specific risk-standardized revascularization rates. Mixed models were fit to assess trends in outcomes after adjustment for demographics, comorbidities, and symptomatic status.

EXPOSURES: Carotid endarterectomy and carotid artery stenting.

MAIN OUTCOMES AND MEASURES: Revascularization rates per 100 000 beneficiary-years of fee-for-service enrollment, in-hospital mortality, 30-day stroke or death, 30-day stroke, myocardial infarction, or death, 30-day all-cause mortality, and 1-year stroke.

RESULTS: During the study, 937 111 unique patients underwent carotid endarterectomy (mean age, 75.8 years; 43% women) and 231 077 underwent carotid artery stenting (mean age, 75.4 years; 49% women). There were 81 306 patients who underwent endarterectomy in 1999 and 36 325 in 2014; national rates per 100 000 beneficiary-years decreased from 298 in 1999-2000 to 128 in 2013-2014 (P < .001). The number of patients who underwent stenting ranged from 10 416 in 1999 to 22 865 in 2006 (an increase per 100 000 beneficiary-years from 40 in 1999-2000 to 75 in 2005-2006; P < .001); by 2014, there were 10 208 patients who underwent stenting and the rate decreased to 38 per 100 000 beneficiary-years (P < .001). Outcomes improved over time despite increases in vascular risk factors (eg, hypertension prevalence increased from 67% to 81% among patients who underwent endarterectomy and from 61% to 70% among patients who underwent stenting) and the proportion of symptomatic patients (all P < .001). There were adjusted annual decreases in 30-day ischemic stroke or death of 2.90% (95% CI, 2.63% to 3.18%) among patients who underwent endarterectomy and 1.13% (95% CI, 0.71% to 1.54%) among patients who underwent stenting; an absolute decrease from 1999 to 2014 was observed for endarterectomy (1.4%; 95% CI, 1.2% to 1.5%) but not stenting (-0.1%; 95% CI, -0.5% to 0.4%). Rates for 1-year ischemic stroke decreased after endarterectomy (absolute decrease, 3.5% [95% CI, 3.2% to 3.7%]; adjusted annual decrease, 2.17% [95% CI, 2.00% to 2.34%]) and stenting (absolute decrease, 1.6% [95% CI, 1.2% to 2.1%]; adjusted annual decrease, 1.86% [95% CI, 1.45%-2.26%]). Additional improvements were noted for in-hospital mortality, 30-day stroke, myocardial infarction, or death, and 30-day all-cause mortality as well as within demographic subgroups.

CONCLUSIONS AND RELEVANCE: Among fee-for-service Medicare beneficiaries, the performance of carotid endarterectomy declined from 1999 to 2014, whereas the performance of carotid artery stenting increased until 2006 and then declined from 2007 to 2014. Outcomes improved despite increases in vascular risk factors.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Lichtman JH, Jones MR, Leifheit EC, et al. Carotid Endarterectomy and Carotid Artery Stenting in the US Medicare Population, 1999-2014. JAMA. 2017. PMID: 28975306. doi:10.1001/jama.2017.12882

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。